(Q40160140)

18 September 2017

title

Aberrant myeloid marker expression in precursor B-cell and T-cell leukemias (English)

1 reference

18 September 2017

Jeanann L Suggs

1

1 reference

18 September 2017

Julius M Cruse

series ordinal

2

1 reference

18 September 2017

Robert E Lewis

series ordinal

3

1 reference

18 September 2017

publication date

7 September 2007

1 reference

Experimental and Molecular Pathology

18 September 2017

published in

1 reference

18 September 2017

volume

83

1 reference

18 September 2017

issue

3

1 reference

18 September 2017

page(s)

471-473

1 reference

Monoclonal antibodies for the treatment of acute myeloid leukemia

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.08.012

Anti-CD19 immunotoxin enhances the activity of chemotherapy in severe combined immunodeficient mice with human pre-B acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.08.012

The immunophenotype of pre-TALL/LBL revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.08.012

Monoclonal antibody-based therapeutics for leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.08.012

10.1016/J.YEXMP.2007.08.012

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference